封面
市場調查報告書
商品編碼
1701097

生命科學分析市場規模、佔有率、成長分析(按組件、按類型、按應用、按交付模式、按最終用戶、按地區)—2025 年至 2032 年行業預測

Life Science Analytics Market Size, Share, and Growth Analysis, By Component (Software, Services), By Type (Descriptive Analytics, Predictive Analytics), By Application, By Delivery Mode, By End-User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2023 年生命科學分析市場規模價值 298.6 億美元,預計將從 2024 年的 332.6 億美元成長到 2032 年的 780.9 億美元,預測期內(2025-2032 年)的複合年成長率為 11.4%。

生命科學分析市場預計將經歷顯著成長,這得益於電子健康記錄、臨床試驗、基因組測序、穿戴式設備和社交媒體等不同來源的醫療保健數據量呈指數級成長。儘管面臨資料隱私和整合等挑戰,該行業也提供了重大機會,特別是透過整合人工智慧 (AI) 和機器學習 (ML) 來增強藥物發現和個人化醫療。在生命科學領域,全球範圍內都存在著基於證據的決策的需求,而且這種趨勢正在加速。分析可以幫助開發人員推動藥物開發創新、改善患者照護、提高業務效率,並利用豐富的醫療保健數據在快速發展的環境中策略性地定位自己。

目錄

介紹

  • 調查目的
  • 研究範圍
  • 定義

調查方法

  • 資訊採購
  • 二次資料和一次資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分機會分析

市場動態與展望

  • 市場概覽
  • 市場規模
  • 市場動態
    • 促進因素和機會
    • 限制與挑戰
  • 波特的分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 主要投資機會
  • 市場生態系統
  • 市場吸引力指數(2024年)
  • PESTEL分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 技術進步
  • 監管格局

生命科學分析市場規模(依組成部分及複合年成長率) (2025-2032)

  • 市場概覽
  • 軟體
    • 本地解決方案
    • 雲端基礎的解決方案
    • 基於SAAS的解決方案
  • 服務
    • 託管服務
    • 分析服務
    • 諮詢服務
    • 專業服務
    • 培訓與實施
    • 維護和支援服務
    • 其他

生命科學分析市場規模(按類型和複合年成長率)(2025-2032)

  • 市場概覽
  • 說明分析
  • 預測分析
  • 指示性分析

生命科學分析市場規模(按應用和複合年成長率)(2025-2032)

  • 市場概覽
  • 研究與開發
    • 臨床試驗
    • 臨床前和藥物發現
  • 商業分析
    • 銷售和行銷支持
    • 市場進入
    • RWE 和價值證據
    • 參與服務
  • 監理合規
  • 製造和供應鏈最佳化
  • 安全
    • 藥物警戒
    • 醫療設備安全
    • 診斷警報

生命科學分析市場規模(依交付模式和複合年成長率)(2025-2032)

  • 市場概覽
  • 本地
  • 雲端基礎

生命科學分析市場規模(按最終用戶和複合年成長率) (2025-2032)

  • 市場概覽
  • 製藥和生物技術公司
  • 醫療設備公司
  • 研究中心
  • 第三方管理員
  • 其他

生命科學分析市場規模(按地區)及複合年成長率(2025-2032)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業市場定位(2024年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市場佔有率分析(2024年)
  • 主要企業簡介
    • 公司詳情
    • 產品系列分析
    • 公司分部佔有率分析
    • 收益與前一年同期比較對比(2022-2024 年)

主要企業簡介

  • Accenture(Ireland)
  • Cognizant(USA)
  • IBM Corporation(USA)
  • MaxisIT(USA)
  • Oracle Corporation(USA)
  • IQVIA(USA)
  • SAS Institute Inc.(USA)
  • EXL Service(Scioinspire Corp.)(USA)
  • Take Solutions Limited(India)
  • Wipro Limited(India)
  • Dynata(USA)
  • M3(EU)Ltd(UK)
  • Serma Group(France)
  • Apollo Intelligence(USA)
  • Allscripts Healthcare Solutions(USA)
  • Cerner Corporation(USA)
  • Optum(USA)
  • Microsoft(USA)
  • Infosys Limited(India)

結論和建議

簡介目錄
Product Code: SQMIG35G2221

Life Science Analytics Market size was valued at USD 29.86 Billion in 2023 and is poised to grow from USD 33.26 Billion in 2024 to USD 78.09 Billion by 2032, growing at a CAGR of 11.4% during the forecast period (2025-2032).

The life science analytics market is poised for substantial growth, propelled by the escalating volume of healthcare data generated from diverse sources like electronic health records, clinical trials, genomic sequencing, wearables, and social media. Despite facing challenges such as data privacy and integration, the sector presents remarkable opportunities, particularly through the integration of artificial intelligence (AI) and machine learning (ML) to enhance drug discovery and personalized medicine. The global demand for evidence-based decision-making in life sciences further fuels this trend. Organizations can harness analytics to drive innovation in drug development, elevate patient care, and improve operational efficiency, positioning themselves strategically in this rapidly evolving landscape by leveraging the wealth of healthcare data available.

Top-down and bottom-up approaches were used to estimate and validate the size of the Life Science Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Life Science Analytics Market Segments Analysis

The global life science analytics market is segmented based on type, component, delivery, application, end-user and region. Based on type, the market is segmented into descriptive, predictive, and prescriptive. Based on component, the market is segmented into software, and services. In terms of delivery, the market is segmented into on-premise model, and on-demand model. Based on application, the market is segmented into research & development, preclinical trials, clinical trials, sales & marketing, regulatory compliance, supply chain optimization, pharmacovigilance. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, medical device companies, research centers, and third-party administrators. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Life Science Analytics Market

The increasing use of real-world data, such as electronic health records, wearable devices, and social media interactions, is significantly fueling the demand for analytics solutions in the Life Science Analytics market. This type of data offers critical insights into patient outcomes, the effectiveness of treatments, and overall population health trends. By leveraging these insights, stakeholders in the life sciences industry can make informed, evidence-based decisions that enhance patient care and optimize health outcomes. The shift towards data-driven approaches is thus pivotal in transforming the landscape of life sciences, prompting a growing need for advanced analytics capabilities.

Restraints in the Life Science Analytics Market

The Life Science Analytics market faces significant challenges due to the handling of sensitive patient information, which raises critical issues surrounding data privacy and security. Stringent regulations and compliance mandates, such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), complicate data governance for organizations. Navigating these legal frameworks is essential to ensure the protection of patient confidentiality, but it can also create logistical hurdles and increased operational costs. As companies strive to adhere to these regulations, they may encounter difficulties that hamper innovation and slow down the overall growth of the market.

Market Trends of the Life Science Analytics Market

The Life Science Analytics market is experiencing a pronounced trend towards real-time analytics, significantly transforming decision-making processes within the industry. As organizations strive for agility in an increasingly dynamic environment, the demand for real-time data integration, processing, and analysis is intensifying. This shift is particularly evident in sectors like personalized medicine, where timely insights can enhance treatment outcomes, and in patient monitoring, which necessitates immediate data-driven responses. Furthermore, supply chain optimization is being revolutionized by real-time insights, allowing firms to adapt swiftly to fluctuations in demand and improve operational efficiency. Thus, the ability to harness real-time analytics is becoming a critical competitive differentiator in the life sciences landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape

Global Life Science Analytics Market Size by Component & CAGR (2025-2032)

  • Market Overview
  • Software
    • On-Premise Solutions
    • Cloud-Based Solutions
    • SAAS-Based Solutions
  • Services
    • Managed Services
    • Analytical Services
    • Consulting Services
    • Professional Services
    • Training & Implementation
    • Maintenance & Support Services
    • Other

Global Life Science Analytics Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics

Global Life Science Analytics Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Research and Development
    • Clinical Trials
    • Preclinical & Drug Discovery
  • Commercial Analytics
    • Sales & Marketing Support
    • Market Access
    • RWE & Value Evidence
    • Engagement Services
  • Regulatory Compliance
  • Manufacturing & Supply Chain Optimization
  • Safety
    • Pharmacovigilance
    • Medical Device Safety
    • Diagnostic Vigilance

Global Life Science Analytics Market Size by Delivery Mode & CAGR (2025-2032)

  • Market Overview
  • On-Premises
  • Cloud-Based

Global Life Science Analytics Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Research Centers
  • Third-Party Administrators
  • Others

Global Life Science Analytics Market Size & CAGR (2025-2032)

  • North America (Component, Type, Application, Delivery Mode, End-User)
    • US
    • Canada
  • Europe (Component, Type, Application, Delivery Mode, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Component, Type, Application, Delivery Mode, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Component, Type, Application, Delivery Mode, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Component, Type, Application, Delivery Mode, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Accenture (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cognizant (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IBM Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MaxisIT (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oracle Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IQVIA (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SAS Institute Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EXL Service (Scioinspire Corp.) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Take Solutions Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wipro Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dynata (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • M3 (EU) Ltd (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Serma Group (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apollo Intelligence (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Allscripts Healthcare Solutions (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cerner Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optum (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Microsoft (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Infosys Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations